Topic

California

A collection of 492 issues

How to Get Oxlumo (Lumasiran) Covered by UnitedHealthcare in California: Complete Guide with Forms and Appeal Scripts

Answer Box: Getting Oxlumo Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Oxlumo (lumasiran) to treat primary hyperoxaluria type 1 (PH1) in California, with no step therapy required. You need genetic testing confirming AGXT mutations, baseline urinary oxalate levels, and a specialist prescriber (nephrologist/geneticist/urologist). Fastest approval
6 min read

How to Get Aldurazyme (laronidase) Covered by Blue Cross Blue Shield in California: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Aldurazyme Coverage in California Blue Shield of California covers Aldurazyme (laronidase) as a specialty drug requiring prior authorization for MPS I patients. The fastest path to approval: (1) Gather genetic/enzymatic confirmation of MPS I diagnosis, (2) Document baseline disease severity and prior treatment failures, (3) Submit
6 min read

Myths vs. Facts: Getting Somatuline Depot (Lanreotide) Covered by Aetna CVS Health in California

Answer Box: Getting Somatuline Depot Covered by Aetna CVS Health in California Aetna CVS Health requires prior authorization for Somatuline Depot (lanreotide) with specific criteria for acromegaly, GEP-NETs, and carcinoid syndrome. Key requirements include elevated IGF-1 levels, endocrinologist/oncologist prescription, and often prior octreotide trial. Fastest path: Submit complete PA
5 min read

How to Get Cresemba (Isavuconazole) Covered by Blue Cross Blue Shield in California: Prior Authorization Forms, Appeals & Timelines

Answer Box: Getting Cresemba Covered by Blue Cross Blue Shield in California Blue Cross Blue Shield California requires prior authorization for all Cresemba (isavuconazole) requests. Submit clinical documentation showing confirmed invasive aspergillosis or mucormycosis (ICD-10 codes B46.0-B46.9) via AuthAccel portal or fax. If denied, file an internal appeal
6 min read

How to Get Kymriah (tisagenlecleucel) Covered by Blue Shield of California: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Kymriah Covered by Blue Shield of California Blue Shield of California covers Kymriah (tisagenlecleucel) for eligible patients with relapsed/refractory B-cell ALL and lymphomas, requiring prior authorization with medical records submission. To get approved: (1) Ensure you meet the medical necessity criteria including CD19-positive disease and 2+
7 min read

How to Get Breyanzi (Lisocabtagene Maraleucel) Covered by Aetna CVS Health in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Breyanzi Approved by Aetna CVS Health in California Breyanzi (lisocabtagene maraleucel) requires mandatory prior authorization from Aetna CVS Health under their medical benefit, with standard decisions taking 30-45 days. Submit via Availity provider portal or fax to 1-877-269-9916 at least 2 weeks before treatment. If denied, California
7 min read

Work With Your Doctor to Get Therakos CELLEX Photopheresis Covered by Humana in California: Complete Prior Authorization Guide

Answer Box: Getting Therakos CELLEX Covered by Humana in California Humana Medicare Advantage requires prior authorization for Therakos CELLEX photopheresis (ECP) following Medicare NCD 110.4 criteria. Coverage applies for cutaneous T-cell lymphoma (CTCL) refractory to ≥1 prior systemic therapy and steroid-refractory graft-versus-host disease (GVHD). Submit PA through Humana provider
6 min read

Getting Somatuline Depot (Lanreotide) Covered by UnitedHealthcare in California: Complete Prior Authorization and Billing Guide

Answer Box: Your Path to Coverage Getting Somatuline Depot (lanreotide) covered by UnitedHealthcare in California requires prior authorization through OptumRx. Start with proper medical coding: ICD-10 E22.0 for acromegaly or appropriate NET codes, HCPCS J1930 (1 mg per unit), and correct NDCs. UnitedHealthcare often requires step therapy with octreotide
5 min read